Herbalife International
April 30, 2025
LOS ANGELES, April 30, 2025 --
Herbalife reported first-quarter 2025 net sales of 1.22 billion dollars, down 3.4 percent from a year earlier, including a 480 basis point headwind from currency, and up 1.4 percent in constant currency. Net income was 50.4 million dollars, or 0.49 dollars per diluted share, and adjusted earnings were 0.59 dollars per share. Adjusted EBITDA was 164.9 million dollars, with the margin up 260 basis points to 13.5 percent, and the company's leverage ratio improved to 3.0 times.
New distributors rose 16 percent from a year earlier. During the quarter Herbalife completed the purchase of assets of Pro2col Health and Pruvit Ventures and formed HBL Link Bioscience, in which it holds a 51 percent stake, to acquire the assets of Link BioSciences.
For the second quarter, the company guided to net sales ranging from a 3.5 percent decline to 0.5 percent growth and adjusted EBITDA of 160 million to 170 million dollars. It narrowed its full-year sales outlook to a range of a 2.5 percent decline to 2.5 percent growth, raised its adjusted EBITDA guidance to 625 million to 655 million dollars from 600 million to 640 million dollars, and cut planned capital expenditures to 90 million to 120 million dollars. The results were the last reported before Stephan Gratziani was due to take over as chief executive on May 1.